Increased expression of VEGF and CD146 in patients with inflammatory bowel disease

Digestive and Liver Disease

Volumn 40, Issue 8, 2008, Pages 673-679

  Tsiolakidou, G ^a   Koutroubakis, I E ^a   Tzardi, M ^a   Kouroumalis, E A ^a  

^a UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

Author keywords

Angiogenesis; Crohn's disease; Immunohistochemistry; Microvessel density; Ulcerative colitis

Indexed keywords

AZATHIOPRINE; CD146 ANTIGEN; CD34 ANTIGEN; INFLIXIMAB; METHOTREXATE; SALAZOSULFAPYRIDINE; STEROID; VASCULOTROPIN;

ADULT; ANGIOGENESIS; ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; COLON MUCOSA; COLONOSCOPY; CONTROLLED STUDY; CROHN DISEASE; DISEASE ACTIVITY; ENTERITIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INTESTINE BIOPSY; MALE; PATHOGENESIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; ULCERATIVE COLITIS;

ADULT; ANTIGENS, CD146; ANTIGENS, CD34; COLITIS, ULCERATIVE; COLON; CROHN DISEASE; ENDOTHELIAL CELLS; FEMALE; HUMANS; INTESTINAL MUCOSA; MALE; MIDDLE AGED; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 45849123466     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2008.02.010     Document Type: Article

References (33)

1. Hatoum O.A., Binion D.G., and Gutterman D.D. Paradox of simultaneous intestinal ischaemia and hyperaemia in inflammatory bowel disease. Eur J Clin Invest 35 (2005) 599-609
2. Griga T., Tromm A., Spranger J., and May B. Increased serum levels of vascular endothelial growth factor in patients with inflammatory bowel disease. Scand J Gastroenterol 33 (1998) 504-508
3. Griga T., Voigt E., Gretzer B., Brasch F., and May B. Increased production of vascular endothelial growth factor by intestinal mucosa of patients with inflammatory bowel disease. Hepatogastroenterology 46 (1999) 920-923
4. Kanazawa S., Tsunoda T., Onuma E., Majima T., Kagiyama M., and Kikuchi K. VEGF, basic-FGF, and TGF-beta in Crohn's disease and ulcerative colitis: a novel mechanism of chronic intestinal inflammation. Am J Gastroenterol 96 (2001) 822-828
5. Griga T., May B., Pfisterer O., Müller K.M., and Brasch F. Immunohistochemical localization of vascular endothelial growth factor in colonic mucosa of patients with inflammatory bowel disease. Hepatogastroenterology 49 (2002) 116-123
6. Di Sabatino A., Ciccocioppo R., Armellini E., Morera R., Ricevuti L., Cazzola P., et al. Serum bFGF and VEGF correlate respectively with bowel wall thickness and intramural blood flow in Crohn's disease. Inflamm Bowel Dis 10 (2004) 573-577
7. Konno S., Iizuka M., Yukawa M., Sasaki K., Sato A., Horie Y., et al. Altered expression of angiogenic factors in the VEGF- Ets-1 cascades in inflammatory bowel disease. J Gastroenterol 39 (2004) 931-939
8. Ferrante M., Pierik M., Henckaerts L., Joossens M., Claes K., Van Schuerbeek N., et al. The role of vascular endothelial growth factor (VEGF) in inflammatory bowel disease. Inflamm Bowel Dis 12 (2006) 870-878
9. Hanabata N., Sasaki Y., Tanaka M., Tsuji T., Hatada Y., Hada R., et al. Vascular endothelial growth factor expression and microvessel parameters of colonic mucosa correlate with sensitivity to steroid in patients with ulcerative colitis. Scand J Gastoenterol 40 (2005) 188-193
10. Danese S., Sans M., de la Motte C., Graziani C., West G., Phillips M.H., et al. Angiogenesis as a novel component of inflammatory bowel disease pathogenesis. Gastroenterology 130 (2006) 2060-2073
11. Koutroubakis I.E., Xidakis C., Karmiris K., Sfiridaki A., Kandidaki E., and Kouroumalis E.A. Serum angiogenin in inflammatory bowel disease. Dig Dis Sci 49 (2004) 1758-1762
12. Koutroubakis I.E., Xidakis C., Karmiris K., Sfiridaki A., Kandidaki E., and Kouroumalis E.A. Potential role of soluble angiopoietin-2 and tie-2 in patients with inflammatory bowel disease. Eur J Clin Invest 36 (2006) 127-132
13. Saito S., Tsuno N.H., Sunami E., Hori N., Kitayama J., Kazama S., et al. Expression of platelet-derived endothelial cell growth factor in inflammatory bowel disease. J Gastroenterol 38 (2003) 229-237
14. Chidlow J.H., Shukla D., Grisham M.B., and Kevil C.G. Pathogenic angiogenesis in IBD and experimental colitis: new ideas and therapeutic avenues. Am J Physiol Gastrointest Liver Physiol 293 (2007) G5-G18
15. Koutroubakis I.E., Tsiolakidou G., Karmiris K., and Kouroumalis E.A. Role of angiogenesis in inflammatory bowel disease. Inflamm Bowel Dis 12 (2006) 515-523
16. Vainer B., and Nielsen O.H. Changed colonic profile of P-selectin, platelet-endothelial cell adhesion molecule-1 (PECAM-1), intercellular adhesion molecule-1 (ICAM-1), ICAM-2, and ICAM-3 in inflammatory bowel disease. Clin Exp Immunol 121 (2000) 242-247
17. Vainer B., Sorensen S., Nielsen O.H., and Horn T. Subcellular localization of intercellular adhesion molecule-1 in colonic mucosa in ulcerative colitis. Ultrastruct Pathol 26 (2002) 113-121
18. Danese S., Semeraro S., Marini M., Roberto I., Armuzzi A., Papa A., et al. Adhesion molecules in inflammatory bowel disease: therapeutic implications for gut inflammation. Dig Liv Dis 37 (2005) 811-818
19. Bardin N., Reumaux D., Geboes K., Colombel J.F., Blot-Chabaud M., Sampol J., et al. Increased expression of CD146, a new marker of the endothelial junction in active inflammatory bowel disease. Inflamm Bowel Dis 12 (2006) 16-21
20. Fina L., Molgaard H.V., Robertson D., Bradley N.J., Monaghan P., Delia D., et al. Expression of the CD34 gene in vascular endothelial cells. Blood 75 (1990) 2417-2426
21. Kalaria R.N., and Kroon S.N. Expression of leukocyte antigen CD34 by brain capillaries in Alzheimer's disease and neurologically normal subjects. Acta Neuropathol (Berl) 84 (1992) 606-612
22. Baumhueter S., Dybdal N., Kyle C., and Lasky L.A. Global vascular expression of murine CD34, a sialomucine-like endothelial cell ligand for l-selectin. Blood 84 (1994) 2554-2565
23. Seidelin J.B., Vainer B., Horn T., and Nielsen O.H. Circulating l-selectin levels and endothelial CD34 expression in inflammatory bowel disease. Am J Gastroenterol 93 (1998) 1854-1859
24. Burgio V.L., Fais S., Boirivant M., Perrone A., and Pallone F. Periferal monocyte and naïve T-cell recruitment and activation in Crohn's disease. Gastroenterology 109 (1995) 1029-1038
25. Middleton J., Americh L., Gayon R., Julien D., Mansat M., Mansat P., et al. A comparative study of endothelial cell markers expressed in chronically inflamed human tissues: MECA-79, Duffy antigen receptor for chemokines, von Willebrand factor, CD31, CD34, CD105 and CD146. J Pathol 206 (2005) 260-268
26. Lennard-Jones J.E. Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl 24 (1989) 2-6
27. Kapsoritakis A., Sfiridaki A., Maltezos E., Simopoulos K., Giatromanolaki A., Sivridis E., et al. Vascular endothelial growth factor in inflammatory bowel disease. Int J Colorectal Dis 18 (2003) 418-422
28. Magro F., Araujo F., Pereira P., Meireles E., Diniz-Ribeiro M., and Velosom F.T. Soluble selectins. sICAM, sVCAM, and angiogenic proteins in different activity groups of patients with inflammatory bowel disease. Dig Dis Sci 49 (2004) 1265-1274
29. Thornton M., and Solomon M.I. Crohn's disease: in defense of a microvascular aetiology. Int J Colorectal Dis 17 (2002) 287-297
30. Shih I.M. The role of CD146 (Mel-CAM) in biology and pathology. J Pathol 189 (1999) 4-11
31. Bardin N., Anfosso F., Massé J.M., Cramer E., Sabatier F., Le Bivic A., et al. Identification of CD146 as a component of the endothelial junction involved in the control of cell-cell cohesion. Blood 98 (2001) 3677-3684
32. Danese S., Sans M., Spencer D.M., Beck I., Doñate F., Plunkett M.L., et al. Angiogenesis blockade as a new therapeutic approach to experimental colitis. Gut 56 (2007) 855-862
33. Chidlow Jr. J.H., Langston W., Greer J.J., Ostanin D., Abdelbaqi M., Houghton J., et al. Differential angiogenic regulation of experimental colitis. Am J Pathol 169 (2006) 2014-2030